Wisconsin Long-Term Care Urinary Tract Infection (UTI) Toolkit
Developed by the Wisconsin Healthcare-Associated Infections in Long-Term Care Coalition, the objectives of the Wisconsin UTI Improvement Toolkit are to help long-term care facilities:
- Standardize the assessment and communication of findings in residents experiencing a change-in-condition where UTI is suspected.
- Promote the use of active monitoring and delay of urine testing and antibiotic treatment among residents where the risk of UTI is low.
- Promote the appropriate use of antibiotics (drug, dose, duration) in residents where the risk of UTI is high.
- Section 1 provides the background and overview of the Wisconsin Urinary Tract Infection (UTI) Toolkit.
- Section 2 describes the clinical rationale for antibiotic stewardship.
- Section 3 provides an overview of related regulatory information.
- Section 1 provides the background and risk factors for indwelling urinary catheter use and CAUTI.
- Section 2 describes appropriate indications and alternatives for indwelling catheter use.
- Section 3 provides information about indwelling catheter insertion and maintenance and includes links to additional resources, as well as a complete reference list is at the end of the module.
- Section 1 provides a discussion about urinary tract infections, definitions and signs/symptoms.
- Section 2 is an instructive session for nursing home UTI management champions in preparation to educate staff, including an introduction to the UTI Stoplight Tool and When to Test Urine-Nursing Tool.
- Section 3 provides practical application of the When to Test Urine-Nursing Tool to seven case studies.
- Section 4 provides a suggested educational plan for integrating the tools and resources.
- Section 1 provides a discussion of the clinical decision about when to treat a suspected urinary tract infection and the five moments of antibiotic decision-making.
- Section 2 presents basic principles related to initiating treatment, along with guidance about empiric treatment of uncomplicated and complicated urinary tract infection.
- Section 3 reviews opportunities to modify existing antibiotic therapy and reviews antibiotic timeout.
- Section 4 provides an overview of the collaborative role of the pharmacist in antibiotic stewardship, along with sample documents related to a Collaborative Practice Agreement.

